Akebia Therapeutics/ US00972D1054 /
| 2024-05-30 9:59:54 PM | Chg. +0.05 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 1.07USD | +4.90% | 27,151 Turnover: 29,255.15 |
-Bid Size: - | -Ask Size: - | 1.14 | 1.01 |
GlobeNewswire
04-23
AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval...
GlobeNewswire
01-29
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
GlobeNewswire
2023-12-08
FibroGen/Astellas’ EVRENZO (roxadustat) Making In-Roads in European Market as In-Class Challenger, A...
GlobeNewswire
2023-11-13
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Acc...
Newsfile Corp
2022-04-25
AKBA INVESTOR NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Akebia Therapeutics, Inc. Investors...
Newsfile Corp
2022-04-23
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to ...
Newsfile Corp
2022-04-21
ROSEN, A LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors With Losses to Secure Coun...
Newsfile Corp
2022-04-19
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Bef...
Newsfile Corp
2022-04-17
ROSEN, A LEADING AND RANKED FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses Over $1...
Newsfile Corp
2022-04-16
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses Over $100...
Newsfile Corp
2022-04-14
ROSEN, A LEADING AND RANKED FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secu...
GlobeNewswire
2022-03-28
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Riv...
GlobeNewswire
2022-03-24
AKBA INVESTOR NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors...
GlobeNewswire
2022-03-22
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Riv...
GlobeNewswire
2022-03-22
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akebia...
GlobeNewswire
2022-03-18
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Akebia Therapeutic...
GlobeNewswire
2022-03-18
Bronstein, Gewirtz & Grossman, LLC Notifies Akebia Therapeutics, Inc. (AKBA) Shareholders of Class A...
GlobeNewswire
2022-03-18
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to...
GlobeNewswire
2022-03-17
AKEBIA THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces th...
GlobeNewswire
2022-03-16
(AKBA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Akebia Ther...
GlobeNewswire
2022-03-14
Pomerantz Law Firm Announces the Filing of a Class Action Against Akebia Therapeutics, Inc. and Cert...
GlobeNewswire
2022-03-10
American Kidney Fund Awards Two Clinical Scientist in Nephrology Fellowships to Researchers Focused ...
GlobeNewswire
2022-02-28
UPDATE: American Kidney Fund Celebrates Individuals’ ‘Kidney Moments’ During Kidney Month
GlobeNewswire
2022-02-28
American Kidney Fund Celebrates Individuals’ ‘Kidney Moments’ During Kidney Month
GlobeNewswire
2021-10-11
ChemoCentryx Appoints Rita I. Jain, M.D. as Executive Vice President, Chief Medical Officer
